Compare Stocks
Compare up to four stocks to (BNTX) by adding the symbol or company name.
BNTX
Compare up to three stocks to BNTX by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value 20.44B | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV 5.73B | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings 182.90 | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM 0.47 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
Industry | Industry Biotechnology | Industry -- | Industry -- | Industry -- |
CEO | CEO Dr. Ugur Sahin M.D. | CEO -- | CEO -- | CEO -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week -1.64% | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months 1.36% | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD -13.00% | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year -12.76% | 1 Year -- | 1 Year -- | 1 Year -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue 2.73B | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses 2.42B | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income -257.40M | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y -85.31% | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit 2.17B | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory 345.40M | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover 0.67 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops 5.73B | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx -787.60M | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI -8.52B | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow 4.94B | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E 182.90 | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E 161.29 | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF 4.20 | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV 1.04 | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S 7.61 | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA 169.49 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin -9.43% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin 79.38% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin 4.14% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS 0.49 | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth -79.59% | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets 0.51% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital -1.17% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of May 14, 2024 | BNTX BioNTech SE | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % 18.56% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |